ga naar hoofdinhoud
Informatie voor zorgverleners Behandelprotocollen MDS/MPN overlapsyndromen (overige vormen) Richtlijnen en literatuur

Richtlijnen

Er zijn op dit moment geen richtlijnen voor MDS/MPN-T-SF3B1, MDS/MPN-RS-T, NOS en MDS-MPN, NOS. 

Literatuur

  1. Arber DA et al. International consensus classification of myeloid neoplasms and acute leukemias: integrating morphologic, clinical, and genomic data. Blood. 2022; 140(11):1200-28
  2. Khoury JD et al. The 5th edition of the World Health Organization classification of haematolymphoid tumours: myeloid and histiocytic/dendritic neoplasms. Leukemia. 2022; 36(7):1703-19
  3. Broseus J et al. Clinical features and course of refractory anemia with ring sideroblasts associated with marked thrombocytosis. Haematologica. 2012; 97(7):1036-41
  4. Palomo L et al. Molecular landscape and clonal architecture of adult myelodysplastic / myeloproliferative neoplasms. Blood. 2020; 136(16):1851-62
  5. DiNardo CD et al. Myelodysplastic / myeloproliferative neoplasms, unclassifiable (MDS/MPN, U): natural history and clinical outcome by treatment strategy. Leukemia. 2014; 28(4):958-61
  6. Mughal TI et al. An international MDS/MPN working group's perspective and recommendations on molecular pathogenesis, diagnosis and clinical characterization of myelodysplastic / myeloproliferative neoplasms. Haematologica. 2015; 100(9):1117-30
  7. Savona MR et al. An international consortium proposal of uniform response criteria for myelodysplastic / myeloproliferative neoplasms (MDS/MPN) in adults. Blood. 2015; 125(12):1857-65
  8. Mangaonkar AA et al. Clinicopathologic characteristics, prognostication and treatment outcomes for myelodysplastic / myeloproliferative neoplasm, unclassifiable (MDS/MPN-U): Mayo Clinic-Moffitt Cancer Center study of 135 consecutive patients. Leukemia. 2020; 34(2):656-61
  9. Mangaonkar AA et al. Myelodysplastic / myeloproliferative neoplasms with ring sideroblasts and thrombocytosis (MDS/MPN-RS-T): Mayo-Moffitt collaborative study of 158 patients. Blood Cancer J. 2022; 12(2):26

 

Ga terug naar de overige MDS/MPN overlapsyndromen homepage of lees meer over:

Ga terug naar de algemene homepage Behandelprotocollen.